Clik here to view.
Qritive Secures Multi-Year Contracts with Metropolis Healthcare, CŌRE...
MUMBAI, India & SINGAPORE QritiveTM, a leading provider of AI solutions for pathology labs worldwide, announces partnership with esteemed diagnostic centres and hospitals in India: Metropolis...
View ArticleClik here to view.
Delta-Fly Pharma Inc.: Abstracts submission for Phase I Clinical Trial of...
TOKUSHIMA, Japan Following the previous information on Jan. 5th. in 2024, we are excited to share our latest development status. A Phase I clinical dose-finding study of DFP-14927 in patients with...
View ArticleClik here to view.
Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance...
MEDFORD, Mass. Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system...
View ArticleClik here to view.
迈巴制药 (Myrobalan Therapeutics ) CSF1R抑制剂项⽬获得肌萎缩性侧索硬化症协会（ALS Association）资助
梅德福，马萨诸塞州。 (美国商业资讯)– 迈巴制药，一家致力于开发新型口服小分子神经修复疗法，旨在修复中枢神经系统损伤并恢复神经功能，以满足神经退行性疾病中的重大未满足临床需求的生物技术公司，荣幸地宣布从肌萎缩性侧索硬化症协会（ALS...
View ArticleClik here to view.
Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows
NEW YORK & BRISBANE, Australia Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its strategic partnership with Icon Group (Icon), a worldwide...
View ArticleClik here to view.
Coreline Soft Showcases Deep Learning AI Imaging Solutions ‘AVIEW’ at ECR 2024
VIENNA Coreline Soft, a pioneer in medical artificial intelligence (AI) imaging, unveils cutting-edge AI medical imaging solutions at the ECR 2024 (European Congress of Radiology), establishing a...
View ArticleClik here to view.
HistoSonics Awarded Key Position in UK’s Novel Innovation Program
MINNEAPOLIS HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today that the company’s Edison System has been selected to...
View ArticleClik here to view.
HistoSonics成功加入英国新创新计划
明尼阿波利斯 (美国商业资讯)– Edison ®系统和创新组织摧毁术治疗平台制造商HistoSonics®（www.histosonics.com）...
View ArticleClik here to view.
ヒストソニックス、英国の新しいイノベーションプログラムIDAPに参加
MINNEAPOLIS （ビジネスワイヤ） — ヒストソニックス ® （ www.histosonics.com ）は、Edison ® システムのメーカーであり、画期的なヒストトリプシー療法のプラットフォームです。このほど、当社のEdisonシステムは、英国で新たに立ち上げられた Innovative Devices Access Pathway（IDAP）パイロットプログラム...
View ArticleClik here to view.
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for...
TOKYO & BASKING RIDGE, N.J. Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the...
View ArticleClik here to view.
BostonGeneは第21回日本臨床腫瘍学会学術集会にて、最新の診断解析ツールと技術に関する包括的なポートフォリオを発表します。
WALTHAM, Mass. （ビジネスワイヤ） —...
View ArticleClik here to view.
AIメディカルサービス、シンガポール初の胃がん鑑別AI「gastroAI-model G -SG」の機器登録を完了
東京 （ビジネスワイヤ） — 内視鏡の画像診断支援AI（人工知能）を開発する株式会社AIメディカルサービス（本社：東京都豊島区、代表取締役 CEO：多田 智裕、以下「AIM」）は、2024年2月19日にAIを活用した胃病変の腫瘍性・非腫瘍性を判定する内視鏡画像診断支援システム（販売名：Endoscopic image diagnosis support software –...
View ArticleClik here to view.
AI Medical Service Inc. Completes First Regulatory Review and Device...
TOKYO AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory...
View ArticleClik here to view.
BostonGene to Showcase Comprehensive Portfolio of Advanced Diagnostic Tools...
WALTHAM, Mass. BostonGene, a leading provider of AI-based molecular and immune profiling solutions, announced today that it will participate in the 21st Japanese Society of Medical Oncology (JSMO)...
View ArticleClik here to view.
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final...
View ArticleClik here to view.
AI Medical Service Inc.完成新加坡HSA对基于胃人工智能的内窥镜诊断支持系统的首次监管审查和器械注册
东京 (美国商业资讯)– AI MEDICAL SERVICE INC.（以下简称“AIM”）是一家专门从事内窥镜人工智能诊断开发的医疗初创公司。该公司欣然宣布，基于人工智能并在胃内部进行内窥镜诊断支持的器械已通过新加坡监管部门的首次审查和器械注册（品牌名称：内窥镜影像诊断支持软件- gastroAI-model...
View ArticleClik here to view.
Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic...
CAMBRIDGE, Mass. & SINGAPORE Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disorders and...
View ArticleClik here to view.
Clinical Review of Pegylated Interferons Suggests Formulation and Mechanism...
BURLINGTON, Mass. PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven...
View ArticleClik here to view.
ORI Capital Raises $260 Million for Second Life Sciences Fund
HONG KONG & NATICK, Mass. ORI Capital today announced the final close of its second fund, ORI Fund II (the “Fund”), with total commitments of $260 million. This milestone meets the Fund’s...
View ArticleClik here to view.
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today reinforced its continued global expansion, rapid...
View Article